title: Synthesis and structure-activity relationships of 2-pyridones: a novel series of potent DNA gyrase inhibitors as antibacterial agents.
abstract: Two novel series of 2-pyridones were synthesized by transposition of the nitrogen of 4-quinolones to the bridgehead position. This subtle interchange of the nitrogen atom with a carbon atom yielded two novel heterocyclic nuclei, pyrido[1,2-alpha]pyrimidine and quinolizine, which had not previously been evaluated as antibacterial agents and were found to be potent inhibitors of DNA gyrase. Quinolizines with a methyl group at the 9-position such as (S)-45a (ABT-719) demonstrate exceptional broad spectrum antibacterial activity. Most notably, they are active against resistant bacteria such as methicillin-resistant Staphylococcus aureus, vancomycin-resistant strains of enterococci, and ciprofloxacin-resistant organisms. In addition, 2-pyridones also possess favorable physiochemical and pharmacokinetic properties. These 2-pyridones were synthesized from the commercially available starting materials by 10-17 linear transformations. The structure of an adduct yielded by this sequence, (S)-45a (ABT-719), was determined by X-ray crystallographic analysis.
authors: Abbott Laboratories, Abbott Park, Illinois 60064-3500, USA.
authors: Q
authors: Q
authors: Li
authors: D T
authors: DT
authors: Chu
authors: A
authors: A
authors: Claiborne
authors: C S
authors: CS
authors: Cooper
authors: C M
authors: CM
authors: Lee
authors: K
authors: K
authors: Raye
authors: K B
authors: KB
authors: Berst
authors: P
authors: P
authors: Donner
authors: W
authors: W
authors: Wang
authors: L
authors: L
authors: Hasvold
authors: A
authors: A
authors: Fung
authors: Z
authors: Z
authors: Ma
authors: M
authors: M
authors: Tufano
authors: R
authors: R
authors: Flamm
authors: L L
authors: LL
authors: Shen
authors: J
authors: J
authors: Baranowski
authors: A
authors: A
authors: Nilius
authors: J
authors: J
authors: Alder
authors: J
authors: J
authors: Meulbroek
authors: K
authors: K
authors: Marsh
authors: D
authors: D
authors: Crowell
authors: Y
authors: Y
authors: Hui
authors: L
authors: L
authors: Seif
authors: L M
authors: LM
authors: Melcher
authors: J J
authors: JJ
authors: Plattner
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000138:chemical synthesis* / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects*; D018360:Crystallography, X-Ray; D004250:DNA Topoisomerases, Type II / Q000378:metabolism; D004269:DNA, Bacterial / Q000378:metabolism; D004352:Drug Resistance, Microbial; D004791:Enzyme Inhibitors / Q000138:chemical synthesis* / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology; D006090:Gram-Negative Bacteria / Q000187:drug effects; D006094:Gram-Positive Bacteria / Q000187:drug effects; D009682:Magnetic Resonance Spectroscopy; D008826:Microbial Sensitivity Tests; D008958:Models, Molecular; D015394:Molecular Structure; D011728:Pyridones / Q000138:chemical synthesis* / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology; D011807:Quinolizines / Q000138:chemical synthesis* / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology; D051381:Rats; D012995:Solubility; D013329:Structure-Activity Relationship; D059005:Topoisomerase II Inhibitors
chemical_list: D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D004791:Enzyme Inhibitors; D011728:Pyridones; D011807:Quinolizines; D059005:Topoisomerase II Inhibitors; D004250:DNA Topoisomerases, Type II